Search
Patexia Community

Innovation, Technology, and IP News

FDA Approves Qalsody™ for Treatment of ALS

Written by: Douglas W. Crandell, Ph.D. & Robert J. Hilton, Ph.D. On April 25th, 2023, the U.S. Food and Drug Administration (FDA) approved QalsodyTM (tofersen) for the...

Brain Computer Interface Developer Announces $33M Series A, Granted FDA “Breakthrough” Designation

Written by:Tom Cowan Brain computer interface developer Paradromics on May 18, 2023, announced a $33 million Series A funding round as well as a...

If a Case Was Baseless, It Would Have Ended Sooner

Written by: Matthew Pham & Daniel P. Hughes OneSubsea IP UK Limited v. FMC Technologies, Inc. Before Clevenger, Moore, and Dyk.  Appeal from the United States District...

Low-Bar for Corroboration

Written by: Matthew Friedrichs & Daniel P. Hughes MEDTRONIC, INC. v. TELEFLEX INNOVATIONS S.A.R.L. Before Moore, Lourie, and Dyk. Appeal from the Patent Trial and Appeal...

Trademark Monitoring and Enforcement in the Digital Era: Tools and Techniques

In today's digital landscape, protecting your trademarks has become more challenging than ever before. With the rise of e-commerce platforms, social media, and online marketplaces, ...

Feed tagged as "toxicity":
Recent research at Clemson University helpes to understand the biological and ecological implications of nanotechnology on the environment. The research provided... Read More »
A new study has shown that quantum dots are safe in primates over at least a one-year period. The luminescent crystals that hold great promise for both detecting and... Read More »
A new study published in Practical Radiation Oncology, the journal of the American Society for Radiation Oncology, found that breast cancer patients treated with... Read More »
Scientists at Cincinnati Children's Hospital Medical Center have developed a unique compound that blocks inflammation-causing molecules in blood cells known to... Read More »
Menu